Update puberty_blockers.md
This commit is contained in:
parent
981520db05
commit
23bd933204
@ -24,7 +24,7 @@
|
|||||||
* _“Since the mid 1990s, puberty delaying medications have been prescribed to some adolescents (not prepubertal children) with severe and persistent gender dysphoria, in cases in which such distress was aggravated by pubertal development.”_
|
* _“Since the mid 1990s, puberty delaying medications have been prescribed to some adolescents (not prepubertal children) with severe and persistent gender dysphoria, in cases in which such distress was aggravated by pubertal development.”_
|
||||||
* _“The Royal College of Psychiatrists, in 1998, **recommended delaying puberty** in young adolescents who experienced strong and persistent ‘cross-sex identification’ and distress around the physical body that intensifies with the onset of puberty.”_
|
* _“The Royal College of Psychiatrists, in 1998, **recommended delaying puberty** in young adolescents who experienced strong and persistent ‘cross-sex identification’ and distress around the physical body that intensifies with the onset of puberty.”_
|
||||||
* _“Puberty blockers are not ‘novel' treatment. They were **recommended by prominent bodies of medical opinion** in the UK and internationally over two decades ago, and have thus been part of standard medical treatment for many years.”_
|
* _“Puberty blockers are not ‘novel' treatment. They were **recommended by prominent bodies of medical opinion** in the UK and internationally over two decades ago, and have thus been part of standard medical treatment for many years.”_
|
||||||
* _“GnRHa has been used in the treatment of gender dysphoria** since the mid 1990s**, and their efficacy in delaying puberty in adolescents is documented by **numerous studies and scientific publications**” (21 scientific studies are then listed)_
|
* _“GnRHa has been used in the treatment of gender dysphoria **since the mid 1990s**, and their efficacy in delaying puberty in adolescents is documented by **numerous studies and scientific publications**” (21 scientific studies are then listed)_
|
||||||
* [Endocrine Society Guidelines: Hebree et al 17](https://academic.oup.com/jcem/article/102/11/3869/4157558)
|
* [Endocrine Society Guidelines: Hebree et al 17](https://academic.oup.com/jcem/article/102/11/3869/4157558)
|
||||||
* A clinical practice guideline for puberty blockers
|
* A clinical practice guideline for puberty blockers
|
||||||
* _“Puberty suppression typically **relives distress for trans adolescents** by halting progression of physical changes such as breast growth in trans males and voice deepening in trans females and is reversible in its effects”_
|
* _“Puberty suppression typically **relives distress for trans adolescents** by halting progression of physical changes such as breast growth in trans males and voice deepening in trans females and is reversible in its effects”_
|
||||||
|
Reference in New Issue
Block a user